Infections

Subtype terms (42)

More specific conditions that are subtypes of Infections in the MeSH hierarchy.

• Aneurysm, Infected
• Arthritis, Infectious

  18 drugs (14 approved, 4 experimental)

• Asymptomatic Infections

  11 drugs (10 approved, 1 experimental)

• Bacterial Infections and Mycoses

  17 drugs (11 approved, 6 experimental)

• Bone Diseases, Infectious

  24 drugs (22 approved, 2 experimental)

• Breakthrough Infections
• Cardiovascular Infections
• Catheter-Related Infections

  38 drugs (32 approved, 6 experimental)

• Central Nervous System Infections

  8 drugs (7 approved, 1 experimental)

• Coinfection

  11 drugs approved

• Communicable Diseases

  88 drugs (55 approved, 33 experimental)

• Community-Acquired Infections

  102 drugs (62 approved, 40 experimental)

• Cross Infection

  58 drugs (44 approved, 14 experimental)

• Eye Infections

  12 drugs (8 approved, 4 experimental)

• Focal Infection
• Gingivitis

  93 drugs (21 approved, 72 experimental)

• Hepatitis, Animal
• Intraabdominal Infections

  44 drugs (37 approved, 7 experimental)

• Laboratory Infection

  2 drugs approved

• Latent Infection

  1 drug approved

• Opportunistic Infections

  6 drugs (4 approved, 2 experimental)

• Parasitic Diseases

  33 drugs (24 approved, 9 experimental)

• Pelvic Infection

  6 drugs approved

• Persistent Infection

  16 drugs (9 approved, 7 experimental)

• Poult Enteritis Mortality Syndrome
• Pregnancy Complications, Infectious

  5 drugs (4 approved, 1 experimental)

• Prosthesis-Related Infections

  33 drugs (26 approved, 7 experimental)

• Reproductive Tract Infections

  3 drugs approved

• Respiratory Tract Infections

  303 drugs (149 approved, 154 experimental)

• Sepsis

  339 drugs (208 approved, 131 experimental)

• Sexually Transmitted Diseases

  30 drugs (27 approved, 3 experimental)

• Skin Diseases, Infectious

  44 drugs (38 approved, 6 experimental)

• Soft Tissue Infections

  31 drugs (24 approved, 7 experimental)

• Suppuration
• Toxemia

  11 drugs approved

• Urinary Tract Infections

  214 drugs (126 approved, 88 experimental)

• Vaccine-Preventable Diseases

  32 drugs (11 approved, 21 experimental)

• Vector Borne Diseases

  7 drugs experimental

• Virus Diseases

  139 drugs (70 approved, 69 experimental)

• Waterborne Diseases
• Wound Infection

  68 drugs (48 approved, 20 experimental)

• Zoonoses

  2 drugs (1 approved, 1 experimental)

Drugs by status

Organizations